Biktarvy, formally known as bictegravir sulfate, is a potent single-tablet treatment for controlling HIV infection. This formula combines three key antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the virus's ability to copy within the body, considerably lowering the viral quantity. For many indivi